ArticleCase reports in obstetrics and gynecology2026
Simultaneous Occurrence of Breast Cancer Metastases and Cervical Cancer Metastases in the Same Lymph Node.
Article in Case reports in obstetrics and gynecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: The simultaneous occurrence of different cancer types in the same individual is an uncommon event. We present a case of synchronous metastases of breast cancer and cervical cancer in the same lymph node in a patient with a history of cervical cancer with newly diagnosed breast cancer. Method: This article is a descriptive case report of a single patient treated at our institution. No statistical analysis was performed. Results: Following the recommendation of our interdisciplinary tumor conference, we began treatment with neoadjuvant chemotherapy in reverse order, with four cycles of carboplatin/Taxol (corresponding to first-line chemotherapy for cervical cancer), followed by four cycles of EC (epirubicin and cyclophosphamide) (corresponding to first-line chemotherapy for breast cancer), mammoplasty, and adjuvant radiotherapy, including internal mammary and supraclavicular node irradiation. By adjusting therapy regimens, it was possible to achieve complete remission of both the primary and secondary tumors. Conclusion: The occurrence of synchronous cervical and breast cancer is extremely rare, with only a few cases reported in the literature. A definitive correlation between the two cancers cannot currently be established due to limited cases. Because of this rarity, treatment planning is particularly complex and requires an individualized, multidisciplinary approach. A combination of systemic therapy, radiotherapy, and surgery may achieve complete remission in selected patients, as we saw in our case. Mortality rates remain unclear due to the limited number of reported cases.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.